Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03513952 |
Title | Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Kaiser Permanente-Riverside | Riverside | California | 92505 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
Straub Clinic and Hospital | Honolulu | Hawaii | 96813 | United States | Details | |
University of Hawaii Cancer Center | Honolulu | Hawaii | 96813 | United States | Details | |
University of Chicago Comprehensive Cancer Center | Chicago | Illinois | 60637 | United States | Details | |
East Jefferson General Hospital | Metairie | Louisiana | 70006 | United States | Details | |
Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
FHCC South Lake Union | Seattle | Washington | 98109 | United States | Details |